Given that current clinical guidelines in Korea recommend the ApoB test for specific groups like patients with diabetes mellitus and familial hypercholesterolemia, the observed differences in dyslipidemia prevalence may be influenced by the characteristics of the population studied [19,29,30]. Here, APOB is linked to metabolic syndrome.